AI assistant
BIO-TECHNE Corp — Director's Dealing 2023
Dec 21, 2023
30718_dirs_2023-12-21_40c1948e-54b1-4d28-a648-897a9c3c5d51.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2023-12-19
Reporting Person: Hippel James (CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-12-19 | Common Stock | M | 47289 | $31.26 | Acquired | 104850 | Direct |
| 2023-12-19 | Common Stock | F | 32966 | $77.42 | Disposed | 71884 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-12-19 | Stock Options (Right to Buy) | $31.26 | M | 47289 | Disposed | 2024-08-09 | Common Stock (47289) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $44.33 | 2025-08-08 | Common Stock (168620) | 168620 | Direct |
| Stock Options (Right to Buy) | $47.60 | 2026-08-07 | Common Stock (186068) | 186068 | Direct |
| Stock Options (Right to Buy) | $66.97 | 2027-08-05 | Common Stock (90740) | 90740 | Direct |
| Stock Options (Right to Buy) | $66.97 | 2027-08-05 | Common Stock (76588) | 76588 | Direct |
| Restricted Stock Units | $ | Common Stock (7780) | 7780 | Direct | |
| Stock Options (Right to Buy) | $120.46 | 2028-08-06 | Common Stock (30400) | 30400 | Direct |
| Stock Options (Right to Buy) | $120.46 | 2028-08-06 | Common Stock (40536) | 40536 | Direct |
| Restricted Stock Units | $ | Common Stock (10912) | 10912 | Direct | |
| Stock Options (Right to Buy) | $94.52 | 2029-08-15 | Common Stock (33916) | 33916 | Direct |
| Stock Options (Right to Buy) | $94.52 | 2029-08-15 | Common Stock (45220) | 45220 | Direct |
| Restricted Stock Units | $ | Common Stock (13865) | 13865 | Direct | |
| Stock Options (Right to Buy) | $84.61 | 2030-08-15 | Common Stock (37314) | 37314 | Direct |
| Stock Options (Right to Buy) | $84.61 | 2030-08-15 | Common Stock (45923) | 45923 | Direct |
| Restricted Stock Units | $ | Common Stock (26318) | 26318 | Direct |
Footnotes
F1: Fully exercisable.
F2: Options to purchase 57,440 shares are vested. Options to purchase 19,148 shares vest on 8/5/2024.
F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
F4: Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F5: Options to purchase 20,268 shares are vested. Options to purchase 10,136 shares vest on 8/6/2024 and options to purchase 10,134 shares vest on 8/6/2025.
F6: Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F7: Options to purchase 11,304 shares are vested. Options to purchase 11,304 shares vest on each of 8/15/2025 and 8/15/2026 and options to purchase 11,308 shares vest on 8/15/2024.
F8: Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F9: Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026.
F10: 13,159 restricted stock units vest on each of 11/1/2024 and 11/1/2025.